Compare BBIO & EMBJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBIO | EMBJ |
|---|---|---|
| Founded | 2015 | 1969 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 11.8B |
| IPO Year | 2019 | N/A |
| Metric | BBIO | EMBJ |
|---|---|---|
| Price | $74.18 | $63.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 21 | 0 |
| Target Price | ★ $76.24 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 865.8K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 0.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.45 |
| Revenue | $353,780,000.00 | ★ $7,746,796,250.00 |
| Revenue This Year | $128.44 | N/A |
| Revenue Next Year | $76.14 | $10.84 |
| P/E Ratio | ★ N/A | $138.01 |
| Revenue Growth | ★ 62.46 | 31.44 |
| 52 Week Low | $25.34 | $34.88 |
| 52 Week High | $76.51 | $67.44 |
| Indicator | BBIO | EMBJ |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | N/A |
| Support Level | $72.73 | N/A |
| Resistance Level | $76.51 | N/A |
| Average True Range (ATR) | 2.37 | 0.00 |
| MACD | -0.30 | 0.00 |
| Stochastic Oscillator | 66.40 | 0.00 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.